193 related articles for article (PubMed ID: 28735823)
1. Comparison of remicade to curcumin for the treatment of Crohn's disease: A systematic review.
Schneider A; Hossain I; VanderMolen J; Nicol K
Complement Ther Med; 2017 Aug; 33():32-38. PubMed ID: 28735823
[TBL] [Abstract][Full Text] [Related]
2. Curcuminoids from
Cunha Neto F; Marton LT; de Marqui SV; Lima TA; Barbalho SM
Crit Rev Food Sci Nutr; 2019; 59(13):2136-2143. PubMed ID: 29565637
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Daily JW; Yang M; Park S
J Med Food; 2016 Aug; 19(8):717-29. PubMed ID: 27533649
[TBL] [Abstract][Full Text] [Related]
4. Wormwood (Artemisia absinthium) suppresses tumour necrosis factor alpha and accelerates healing in patients with Crohn's disease - A controlled clinical trial.
Krebs S; Omer TN; Omer B
Phytomedicine; 2010 Apr; 17(5):305-9. PubMed ID: 19962291
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.
Behm BW; Bickston SJ
Cochrane Database Syst Rev; 2008 Jan; (1):CD006893. PubMed ID: 18254120
[TBL] [Abstract][Full Text] [Related]
6. High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's disease.
Martínez-Borra J; López-Larrea C; González S; Fuentes D; Dieguez A; Deschamps EM; Pérez-Pariente JM; López-Vázquez A; de Francisco R; Rodrigo L
Am J Gastroenterol; 2002 Sep; 97(9):2350-6. PubMed ID: 12358255
[TBL] [Abstract][Full Text] [Related]
7. Anti-TNF Therapy Within 2 Years of Crohn's Disease Diagnosis Improves Patient Outcomes: A Retrospective Cohort Study.
Ma C; Beilman CL; Huang VW; Fedorak DK; Kroeker KI; Dieleman LA; Halloran BP; Fedorak RN
Inflamm Bowel Dis; 2016 Apr; 22(4):870-9. PubMed ID: 26818419
[TBL] [Abstract][Full Text] [Related]
8. Curcumin attenuates allergic airway inflammation and hyper-responsiveness in mice through NF-κB inhibition.
Oh SW; Cha JY; Jung JE; Chang BC; Kwon HJ; Lee BR; Kim DY
J Ethnopharmacol; 2011 Jul; 136(3):414-21. PubMed ID: 20643202
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a concomitant elemental diet to reduce the loss of response to adalimumab in patients with intractable Crohn's disease.
Sugita N; Watanabe K; Kamata N; Yukawa T; Otani K; Hosomi S; Nagami Y; Tanaka F; Taira K; Yamagami H; Tanigawa T; Shiba M; Watanabe T; Tominaga K; Kabata D; Shintani A; Arakawa T; Fujiwara Y
J Gastroenterol Hepatol; 2018 Mar; 33(3):631-637. PubMed ID: 28857255
[TBL] [Abstract][Full Text] [Related]
10. Curcumin improves bone microarchitecture and enhances mineral density in APP/PS1 transgenic mice.
Yang MW; Wang TH; Yan PP; Chu LW; Yu J; Gao ZD; Li YZ; Guo BL
Phytomedicine; 2011 Jan; 18(2-3):205-13. PubMed ID: 20637579
[TBL] [Abstract][Full Text] [Related]
11. Curcumin and saikosaponin a inhibit chemical-induced liver inflammation and fibrosis in rats.
Wu SJ; Tam KW; Tsai YH; Chang CC; Chao JC
Am J Chin Med; 2010; 38(1):99-111. PubMed ID: 20128048
[TBL] [Abstract][Full Text] [Related]
12. Oral turmeric/curcumin effects on inflammatory markers in chronic inflammatory diseases: A systematic review and meta-analysis of randomized controlled trials.
White CM; Pasupuleti V; Roman YM; Li Y; Hernandez AV
Pharmacol Res; 2019 Aug; 146():104280. PubMed ID: 31121255
[TBL] [Abstract][Full Text] [Related]
13. Curcumin: therapeutical potential in ophthalmology.
Pescosolido N; Giannotti R; Plateroti AM; Pascarella A; Nebbioso M
Planta Med; 2014 Mar; 80(4):249-54. PubMed ID: 24323538
[TBL] [Abstract][Full Text] [Related]
14. Anti-TNF-alpha loss of response is associated with a decreased percentage of FoxP3+ T cells and a variant NOD2 genotype in patients with Crohn's disease.
Juanola O; Moratalla A; Gutiérrez A; Sempere L; Zapater P; Giménez P; Almenta I; Peiró G; González-Navajas JM; Such JF; Francés R
J Gastroenterol; 2015 Jul; 50(7):758-68. PubMed ID: 25500977
[TBL] [Abstract][Full Text] [Related]
15. Curcumin Protects Against Intestinal Origin Endotoxemia in Rat Liver Cirrhosis by Targeting PCSK9.
Cai Y; Lu D; Zou Y; Zhou C; Liu H; Tu C; Li F; Liu L; Zhang S
J Food Sci; 2017 Mar; 82(3):772-780. PubMed ID: 28196290
[TBL] [Abstract][Full Text] [Related]
16. Certolizumab pegol for the management of Crohn's disease in adults.
Rivkin A
Clin Ther; 2009 Jun; 31(6):1158-76. PubMed ID: 19695385
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's disease: correlation with SES-CD and clinical-biological markers.
Stoppino LP; Della Valle N; Rizzi S; Cleopazzo E; Centola A; Iamele D; Bristogiannis C; Stoppino G; Vinci R; Macarini L
BMC Med Imaging; 2016 May; 16(1):37. PubMed ID: 27149857
[TBL] [Abstract][Full Text] [Related]
18. Effect of tumor necrosis factor-α antagonists on oxidative stress in patients with Crohn's disease.
Yamamoto K; Chiba T; Matsumoto T
World J Gastroenterol; 2015 Sep; 21(35):10208-14. PubMed ID: 26401086
[TBL] [Abstract][Full Text] [Related]
19. Is Curcumin a Possibility to Treat Inflammatory Bowel Diseases?
Mazieiro R; Frizon RR; Barbalho SM; Goulart RA
J Med Food; 2018 Nov; 21(11):1077-1085. PubMed ID: 29957091
[TBL] [Abstract][Full Text] [Related]
20. Single molecule measurements of tumor necrosis factor α and interleukin-6 in the plasma of patients with Crohn's disease.
Song L; Hanlon DW; Chang L; Provuncher GK; Kan CW; Campbell TG; Fournier DR; Ferrell EP; Rivnak AJ; Pink BA; Minnehan KA; Patel PP; Wilson DH; Till MA; Faubion WA; Duffy DC
J Immunol Methods; 2011 Sep; 372(1-2):177-86. PubMed ID: 21821036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
